Intellia Therapeutics (NTLA) PT Lowered to $60 at Oppenheimer
Tweet Send to a Friend
(Updated - November 11, 2024 7:52 AM EST)
Oppenheimer analyst Jay Olson lowered the price target on Intellia Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Jay Olson lowered the price target on Intellia Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
